VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT00462826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

Recurrent Endometrial Carcinoma

Interventions

BIOLOGICAL: ziv-aflibercept

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]